BillA., StjernschantzJ., MandahlA., BrodinE., and NilssonG.Acta Physiol. Scand.106, 371–372(1979)
2.
BruceA.N.Quart. J. exp. Physiol.6, 339–354 (1913)
3.
ButlerJ.M., and HammondB.R.Br. J. Pharmac.69, 495–502 (1980)
4.
BynkeG., HåkansonR., and SundlerF. In: Antidromic Vasodilatation and Neurogenic Inflammation, eds. ChahlL.A., SzolcsanyiJ., and LembeckF., Akademiai Kiadó, Budapest1984, pp. 269–280.
5.
HolmdahlG., HåkansonR., LeanderS., RosellS., FolkersK., and SundlerF.Science214, 1029–1031 (1981)
6.
LeanderS., HåkansonR., RosellS., FolkersK., SundlerF., and TornqvistK.Nature294, 457–469 (1981)
7.
PernowB.Pharm. Rev.35, 85–141 (1983)
8.
SundlerF., BrodinE., EkbladE., HåkansonR., and UddmanR. In: Tachykinin Antagonists, eds. HåkansonR., and SundlerF., Elsevier Science, Amsterdam (1985) pp. 3–14.
9.
WahlestedtC., BedingB., EkmanR., OksalaO., StjernschantzJ., and HåkansonR.Reg. Pep.16, 107–116(1986)